CVS white paper aims to pressure drugmakers to lower GLP-1 prices
GLP-1s would save employers money in the long term if they were priced at $350 a month or less, the pharmacy juggernaut found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.